Avalo Therapeutics, Inc. (AVTX) Reports FY Loss of $114.00

Avalo Therapeutics, Inc. (NASDAQ: AVTX) reported FY EPS of ($114.00). Revenue for the year came in at $1.92 million.

For earnings history and earnings-related data on Avalo Therapeutics, Inc. (AVTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Reading (RDI) Tops Q2 EPS by 4c